437 related articles for article (PubMed ID: 2874214)
1. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
3. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
Katz LB; Tobia AJ; Shriver DA
J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
[TBL] [Abstract][Full Text] [Related]
4. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
5. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of etintidine, a new histamine H2-receptor antagonist.
Scott CK; Katz LB; Shriver DA
Arch Int Pharmacodyn Ther; 1986 May; 281(1):5-21. PubMed ID: 2875695
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
Nielsen ST
J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
[TBL] [Abstract][Full Text] [Related]
10. Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643, 441).
Torchiana ML; Pendleton RG; Cook PG; Hanson CA; Clineschmidt BV
J Pharmacol Exp Ther; 1983 Mar; 224(3):514-9. PubMed ID: 6131118
[TBL] [Abstract][Full Text] [Related]
11. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
12. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
13. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gastric acid secretion by H2-receptor antagonists.
Nielsen ST
Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):151-60. PubMed ID: 2876686
[TBL] [Abstract][Full Text] [Related]
15. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
Poli E; Medici D; Contini GA; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
[TBL] [Abstract][Full Text] [Related]
18. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
19. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
Reeves JJ; Stables R
Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
[TBL] [Abstract][Full Text] [Related]
20. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(4):703-6. PubMed ID: 2861823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
